Andy, Author at BioHealth Innovation

Newswise — Children’s National Hospital and Virginia Tech are expanding their research partnership, building on a successful collaboration established in…

Andy

Love0

News

February 5, 2025

Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist

WASHINGTON and SAN DIEGO, Feb. 3, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) and AnaptysBio, Inc. (Anaptys) (Nasdaq: ANAB) today announced an exclusive, global license…

Andy

Love0

News

February 5, 2025

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the…

Andy

Love0

News

February 4, 2025

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

Over 100,000 patients in the United States have IPF, with only two approved therapies available that only slow the course of disease…

Andy

Love0

News

February 3, 2025

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the…

Andy

Love0

News

February 2, 2025

MCEDC: Nearly $3 Billion Invested in Montgomery County, Maryland Companies in 2024

MONTGOMERY COUNTY, Md. — Businesses in Maryland’s Montgomery County experienced a surge in investment funding in 2024. Mergers and acquisitions,…

Andy

Love0

Andy

Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor

Investing in BioHealth: Dr. Deborah Hemingway on Building Maryland’s Commercialization Hub on BioTalk

Investing in BioHealth: Dr. Deborah Hemingway on Building Maryland’s Commercialization Hub on BioTalk

APT – SCOPE Summit 2025: Emmes’ Peter Ronco on Small Biopharma & Clinical Trial Partnerships

Children’s National Hospital and Virginia Tech Expand Research Partnership to Advance Pediatric Health

Vanda Pharmaceuticals and Anaptys Announce Exclusive Global License Agreement for Vanda to Develop and Commercialize Imsidolimab, an IL-36R Antagonist

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

MCEDC: Nearly $3 Billion Invested in Montgomery County, Maryland Companies in 2024

About BioHealth Innovation

Contact

Connect

Andy

About BioHealth Innovation

Contact

Connect

Search